Related Experiment Video
Updated: May 28, 2026
05:58
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Multiple Endotypes and Angina Burden in Patients With Nonobstructive Coronary Arteries
Christopher C Y Wong1,2,3, Vedant S Pargaonkar1, Luke P Dawson1
1Division of Cardiovascular Medicine, Stanford University School of Medicine and Stanford Cardiovascular Institute, Stanford, California.
JAMA Cardiology
|May 27, 2026
Summary
Coronary function testing (CFT) helps understand chest pain in angina with nonobstructive coronary arteries (ANOCA). More ANOCA endotypes found via CFT correlate with increased angina burden, impacting patient quality of life.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Testing
Background:
- Angina with nonobstructive coronary arteries (ANOCA) presents a diagnostic challenge.
- Coronary function testing (CFT) is crucial for identifying underlying mechanisms in ANOCA.
- The impact of multiple ANOCA endotypes on angina burden requires further investigation.
Purpose of the Study:
- To investigate the association between the number of ANOCA endotypes and patient-reported angina burden.
- To determine if coexisting endotypes in ANOCA patients worsen symptoms.
Main Methods:
- Cross-sectional study of 485 patients with suspected ANOCA undergoing comprehensive CFT.
- Acetylcholine, adenosine, and intravascular ultrasound with hemodynamic testing were used to identify endotypes.
- The Seattle Angina Questionnaire (SAQ) assessed angina burden.
Main Results:
- A significant proportion of ANOCA patients (61%) had two or more endotypes.
- Angina burden, measured by SAQ scores, worsened significantly with an increasing number of identified endotypes (P=.003).
- Each additional endotype was independently associated with lower SAQ scores (B=-3.55; P<.001).
Conclusions:
- Multiple endotypes frequently coexist in ANOCA patients.
- A higher number of CFT-identified endotypes is associated with a greater angina burden.
- These findings highlight the clinical significance of comprehensive CFT in managing ANOCA.
Related Concept Videos
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...